Lexicon Pharmaceuticals Inc. (LXRX)
LXRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.61
-2.42% on the day
Market cap
$716.4M
Small cap
Revenue · 2025
$49.8M
+60.2% on 2024
Net income · 2025
-$50.3M
-101.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | LXRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001062822 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $49.8M |
| Net income | -$50.3M |
| Operating income | -$48.9M |
| Net margin | -101.1% |
| Operating margin | -98.2% |
| Revenue growth | +60.2% |
| Cash | $34.3M |
| Total assets | $185.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 14.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-06 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy DEF 14A | DEFA14A | 2026-03-16 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -9.1% |
| 1 month | -20.4% |
| 3 months | -28.6% |
| Year to date | +39.1% |
| 1 year | +11.1% |
| From 52-week high | -39.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IMMX | Immix Biopharma Inc. | $8.69 | -6.05% | $720.4M |
| ANNX | Annexon Inc. | $3.83 | -3.28% | $726.1M |
| COLL | Collegium Pharmaceutical Inc. | $21.53 | -2.36% | $700.9M |
| OBX | Obsidian Therapeutics Inc. | $11.99 | -6.25% | $740.7M |
| APMD | Apnimed Inc. | $17.83 | -4.29% | $742.3M |
| GYRE | Gyre Therapeutics Inc. | $6.71 | -2.26% | $748.2M |
| IVA | Inventiva S.A. American Depository Shares | $2.87 | -8.01% | $678.1M |
| ANL | Adlai Nortye Group Ltd. | $11.76 | -17.34% | $757.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier